Patients treated with ablation in cardiac electrophysiology studies. Atrial fibrillation and flutter, Paroxysmal tachycardia
Conditions
Interventions
Intervention 1: Vitamin C (ascorbic acid), 1 gram oral tablet, only once in 3 hours prior to the test. Intervention 2: Vitamin C (ascorbic acid), 2 gram oral tablet, only once in 3 hours prior to the
Prevention
Vitamin C (ascorbic acid), 1 gram oral tablet, only once in 3 hours prior to the test
Vitamin C (ascorbic acid), 2 gram oral tablet, only once in 3 hours prior to the test
The control group without action
Sponsors
Vice chancellor for research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Non-smoking; Lack of infectious disease; Do not use of antibiotics; Unexposed to ionizing radiation, 24 hours prior to sampling Exclusion criteria: Use of multivitamins; Use of alcohol; Acute or chronic disease
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Apoptosis. Timepoint: Before the intervention and after intervention within 24 hours after the test. Method of measurement: Counting the number of apoptotic peripheral blood lymphocytes by flow cytometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bax protein. Timepoint: Before intervention and after intervention within 24 hours after the test. Method of measurement: Counting the number of Bax protein by ELISA method.;Bcl-2 protein. Timepoint: Before intervention and after intervention within 24 hours after the test. Method of measurement: Counting the number of Bcl-2 protein by ELISA method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGholamHasan Hadadi
Shiraz University of Medical Sciences
Outcome results
None listed